Department of Internal Medicine, Division of Intensive Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey
Department of Internal Medicine, Division of Hematology, Gazi University Faculty of Medicine, Ankara, Turkey
Turk J Med Sci. 2021 Aug 30;51(4):2095-2100. doi: 10.3906/sag-2012-107.
BACKGROUND/AIM: The aim of the study was to investigate whether treating haematological malignancy (HM) patients in a separate intensive care unit (ICU) would reduce ICU mortality.
HM patients treated by the same ICU team in a general medical ICU (GM-ICU) and a separate haematology ICU (H-ICU) were included in this study. Patients’ demographic characteristics and ICU data were recorded retrospectively. Differences in the ICU course and prognosis between these two groups were determined.
A total of 251 patients (102 from GM-ICU, 149 from H-ICU) were included in this study. The disease severity and organ failure scores at ICU admission and underlying HMs were not different between the two groups. Patients waited longer for admission to GM- ICU. Therapeutic procedures were performed significantly more frequently in GM-ICU. ICU complications were not different between the groups. ICU mortality rates were higher in GM-ICU (59.8% vs 37.6%, p = 0.006).
A separate ICU allocated for haematology patients will allow timely and rapid admission of HM patients to ICU. Thus, mortality rates of HM patients needing ICU care will decline.
背景/目的：本研究旨在探讨将血液恶性肿瘤（HM）患者收治在单独的重症监护病房（ICU）是否会降低 ICU 死亡率。
本研究纳入了由同一 ICU 团队在普通内科 ICU（GM-ICU）和单独的血液科 ICU（H-ICU）治疗的 HM 患者。回顾性记录患者的人口统计学特征和 ICU 数据。确定这两组 ICU 病程和预后的差异。
共纳入 251 例患者（GM-ICU 组 102 例，H-ICU 组 149 例）。两组患者 ICU 入住时的疾病严重程度和器官衰竭评分以及基础 HM 无差异。GM-ICU 组患者等待入住 ICU 的时间更长。GM-ICU 组的治疗操作明显更频繁。两组 ICU 并发症无差异。GM-ICU 的 ICU 死亡率更高（59.8%比 37.6%，p = 0.006）。
为血液科患者分配单独的 ICU 将允许 HM 患者及时快速入住 ICU。因此，需要 ICU 护理的 HM 患者的死亡率将会下降。
